Evidence map›Paper›PMID 30394507›Full record

ArticleCardiology journal2020

Long term outcomes in diabetic patients treated with atherectomy for peripheral artery disease.

Adam J Janas, Krzysztof P Milewski, Piotr P Buszman, Wojciech Trendel, Aleksandra Kolarczyk-Haczyk, Mariusz Hochuł, Maciej Pruski, Wojciech Wojakowski, Paweł E Buszman, Radosław S Kiesz

Open access · goldAbstract read
In one paragraph

Article in Cardiology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Adam J JanasCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland. adamjjanas@gmail.com.
Krzysztof P MilewskiCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Piotr P BuszmanCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Wojciech TrendelCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Aleksandra Kolarczyk-HaczykCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Mariusz HochułCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Maciej PruskiCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Wojciech WojakowskiCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Paweł E BuszmanCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
Radosław S KieszCenter for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland, Poland.
American Heart of Poland · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of diabetes has increased significantly in well-developed countries during the last decade and it continues to grow. Diabetes increases the risk of restenosis in patients treated percutaneously for peripheral artery disease. The present study sought to compare outcomes of atherectomy treatment in diabetic (DM) vs. non-diabetic (nDM) patients suffering from peripheral artery disease.

methodBetween 2008 and 2012, 204 revascularization atherectomy procedures were performed on arteries of the lower extremities. The endpoints included target lesion revascularization (TLR), amputation and death. The type of atherectomy (excisional-soft plaque, orbital-calcified plaque, with active aspiration - with a thrombus) was left to operator discretion.

resultsThis study contains 132 DM (66% male, age 68 ± 11.2 years) and 72 nDM (63% male, age 75 ± 11.3 years) subjects. DM were younger but had a higher prevalence of coronary artery disease (DM: 91% vs. nDM: 62%, p < 0.0001) and end-stage renal disease (DM: 22% vs. nDM: 2.5%, p < 0.0001). There were no differences in critical limb ischemia between the groups (DM: 21% vs. nDM: 12%, p = = 0.13). Mean time of follow-up was 384 and 411 days in DM and nDM, respectively (p = 0.43). There were no significant differences in TLR (DM: 15.2% vs. nDM: 22.2%, p = 0.249), amputations (DM: 3.0% vs. nDM: 1.5%, p = NS) or death rates (DM: 2.2% vs. nDM: 2.7%, p = NS). Kaplan-Mayer analysis showed no significant differences between the groups in the time to TLR, amputation or death.

conclusionsPlaque modification with adjusted atherectomy appears to have similar outcomes in diabetic as well as in non-diabetic patients. Nonetheless, a randomized study would be warranted to confirm the findings of the current study.

Indexed as

Diabetes MellitusPeripheral Arterial DiseaseAgedAged, 80 and overAmputation, SurgicalAtherectomyCoronary Artery DiseaseFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsTreatment Outcomeabove the kneeatherectomybelow the kneeclaudicationcritical limb ischemiadiabetes mellitusperipheral artery disease

Identifiers

PMID30394507
PMCPMC8078980
OpenAlexW2900219804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.